Cuimin Ding
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 6
- Gastric Cancer Management and Outcomes 5
- Oncology 16
- Lung Cancer Research Studies 11
- Co-authors
- Zhanjun Guo (4 shared papers)Ruijuan Li (3 shared papers)Shengmian Li (2 shared papers)Bin Li (5 shared papers)Bin Li (2 shared papers)Hui Ge (2 shared papers)Ping Wang (1 shared paper)Hao Jin (1 shared paper)
- Journals
- Journal of Thoracic Oncology (6 papers)The Lancet Respiratory Medicine (4 papers)Oncology Reports (2 papers)Lung Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Cuimin Ding
54 papers receiving 1.3k citations
Cuimin Ding's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 519
- Cancer Research 244
- Pulmonary and Respiratory Medicine 518
- Molecular Biology 295
- Immunology 46
Countries citing papers authored by Cuimin Ding
This map shows the geographic impact of Cuimin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuimin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuimin Ding more than expected).
Fields of papers citing papers by Cuimin Ding
This network shows the impact of papers produced by Cuimin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuimin Ding. The network helps show where Cuimin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Cuimin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 186 | |
| 2 | Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial Hit paper breakdown → | 2022 | 178 |
| 3 | Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 149 |
| 4 | 2023 | 51 | |
| 5 | 2021 | 48 | |
| 6 | 2023 | 48 | |
| 7 | 2016 | 37 | |
| 8 | 2012 | 36 | |
| 9 | MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. | 2015 | 33 |
| 10 | 2012 | 33 | |
| 11 | 2021 | 33 | |
| 12 | 2018 | 32 | |
| 13 | 2024 | 29 | |
| 14 | 2020 | 28 | |
| 15 | 2017 | 24 | |
| 16 | 2023 | 22 | |
| 17 | 2013 | 21 | |
| 18 | 2015 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2022 | 20 |
About Cuimin Ding
Cuimin Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Rheumatology, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (11 papers), MicroRNA in disease regulation (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers), Gastric Cancer Management and Outcomes (5 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (519 citations), Cancer Research (244 citations), Pulmonary and Respiratory Medicine (518 citations), Molecular Biology (295 citations) and Immunology (46 citations). Cuimin Ding has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Zhanjun Guo, Ruijuan Li, Shengmian Li, Bin Li, Bin Li, Hui Ge, Ping Wang, Bin Li, Hao Jin and Wei Liu. Their work appears in journals such as Journal of Thoracic Oncology, The Lancet Respiratory Medicine, Oncology Reports, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.